drugset / Trial / NCT03792100

Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition

NCT03792100 ↗

Phase 3 Completed 273 enrolled Fresenius Kabi Parexel · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The present protocol describes a randomized, patient-blinded study in which either SmofKabiven emulsion for infusion or a hospital compounded "All in one" control Total Parenteral Nutrition (TPN) regimen will be given to adult surgical patients for 5 consecutive days. As serum prealbumin is a well-established surrogate efficacy parameter reflecting the patient´s nutritional status, the change of the serum prealbumin level at the day of the final study visit compared to baseline will represent the primary efficacy parameter in the present study.

Timeline

Start
2019-01-03
Primary completion
2020-01-23
Completion
2020-01-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hospital compounded "All in one" emulsion Unknown 26.3 ml Intravenous
Subject SmofKabiven emulsion for infusion Unknown 26.3 ml Intravenous

Indications

No indication recorded.